Jenny Sanchez
Nurse Practitioner · Reno, NVNPI 1841744745
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $479 and has fallen 62.1% since, to $182 in 2025.
Across 71 payments — averaging $23.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$351
- AstraZeneca$247
- Calliditas Therapeutics US Inc.$168
- GSK$132
- Optinose US, Inc.$121
- Bayer$86
- plus $574 from 16 others
What the payments were for
- Food & beverage$1,678100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 16 | $351 |
| AstraZeneca | 8 | $247 |
| Calliditas Therapeutics US Inc. | 9 | $168 |
| GSK | 7 | $132 |
| Optinose US, Inc. | 2 | $121 |
| Bayer | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $83 |
| Sanofi | 2 | $57 |
| Aurinia Pharma U.S., Inc. | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Vifor Pharma, Inc. | 2 | $47 |
| Travere Therapeutics, Inc. | 2 | $40 |
| Ardelyx, Inc. | 2 | $38 |
| Mallinckrodt Hospital Products Inc. | 2 | $37 |
| EUSA Pharma (US) LLC | 1 | $26 |
| Recordati_rare_diseases_inc. | 1 | $26 |
| Abbott | 1 | $24 |
| Novartis | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Chiesi USA, Inc. | 1 | $19 |
| Fresenius USA Marketing, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$118
How this compares
$1,678 in reported general payments places this provider in the 80th percentile of 933 nurse practitioner providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcitriol | 12 | $178 |
| Carvedilol | 12 | $173 |
| Torsemide | 11 | $137 |
| Furosemide | 14 | $58 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Reno
- Melissa DelamoraReno$20K
- Darian ThorpReno$18K
- Mary Beth MedinaReno$11K
- Kristen BowmanReno$10K
- Laura HayReno$8K
- Laura HarshReno$7K
- Mary HelmreichReno$7K
- Rhonda StrunkReno$7K
- Rachael HueftleReno$7K
- Rhonda NavarroReno$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.